BiognoSYS Revenue and Competitors

We believe that the decoding of the proteome will impact life science more than the genome revolution a decade ago. Biognosys provides innovative services and products for protein discovery and quantification using cutting edge technology. We strive to be the company that provides the best possible solutions to support researchers in their protein analysis needs. A New Generation of Protein Quantification Technology. Our next generation technology quantifies proteins with unbeatable precision and depth. The solution is based on mass spectrometry-based targeted proteomics technology, which provides simultaneous quantification for thousands of proteins in a single experiment. Our Mission: Providing Proteomics Solutions to Scientists and Clinicians. We at Biognosys are more than our own research. We make next-generation proteomics widely available with our contract research services and with our portfolio of innovative reagent and software products. Biognosys was founded in 2008 and is a privately held company in Zurich, Switzerland. Originally an ETH Zurich spin-off from the lab of Prof. Ruedi Aebersold, Biognosys is a pioneer in the field of proteomics and caters to the Pharma, Biotech, Diagnostics and Agricultural industries. BIOGNOSYS AG Founded in 2008 as a spin-off from the lab of proteomics pioneer Ruedi Aebersold at ETH Zurich, Biognosys is dedicated to transforming the life sciences with superior proteomics solutions.